0001209191-16-094246.txt : 20160129 0001209191-16-094246.hdr.sgml : 20160129 20160129180818 ACCESSION NUMBER: 0001209191-16-094246 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160127 FILED AS OF DATE: 20160129 DATE AS OF CHANGE: 20160129 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: aTYR PHARMA INC CENTRAL INDEX KEY: 0001339970 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 203435077 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 3545 JOHN HOPKINS COURT, STE #250 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-731-8389 MAIL ADDRESS: STREET 1: 3545 JOHN HOPKINS COURT, STE #250 CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Krueger Nancy CENTRAL INDEX KEY: 0001640869 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37378 FILM NUMBER: 161374844 MAIL ADDRESS: STREET 1: C/O ATYR PHARMA, INC. STREET 2: 3545 JOHN HOPKINS COURT, SUITE 250 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-01-27 0 0001339970 aTYR PHARMA INC LIFE 0001640869 Krueger Nancy 3545 JOHN HOPKINS COURT, SUITE 250 SAN DIEGO CA 92121 0 1 0 0 VP, Legal Affairs Employee Stock Option (right to buy) 6.14 2016-01-27 4 A 0 20000 0.00 A 2026-01-27 Common Stock 20000 20000 D The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on February 1, 2016, such that this option will be fully exercisable on January 1, 2020. This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer. /s/ Nancy Krueger 2016-01-27